Lv51
1580 积分 2023-07-20 加入
Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy
2小时前
已完结
Cardiac and skeletal muscle delivery of biotherapeutics with a blood vessel epicardial substance-targeting peptide
2小时前
已完结
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy
3小时前
已完结
Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives
3小时前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
29天前
已完结
The therapeutic age of the neonatal Fc receptor
30天前
已完结
Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins
1个月前
已完结
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
1个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
1个月前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
2个月前
已完结
皖公网安备34019202002308
